{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:42:26Z","timestamp":1790199746117,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vascn.2022.107228","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T12:50:24Z","timestamp":1666270224000},"page":"107228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Importance of beating rate control for the analysis of drug effects on contractility in human induced pluripotent stem cell-derived cardiomyocytes"],"prefix":"10.1016","volume":"118","author":[{"given":"Yuto","family":"Hinata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2022.107228_bb0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","article-title":"A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes","volume":"84","author":"Ando","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2022.107228_bb0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1113\/jphysiol.1981.sp013675","article-title":"The effects of heart rate on the action potential of guinea-pig and human ventricular muscle","volume":"313","author":"Attwell","year":"1981","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.vascn.2022.107228_bb0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2022.107228_bb0020","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1111\/bph.15868","article-title":"Planning experiments: Updated guidance on experimental design and analysis and their reporting III","volume":"179","author":"Curtis","year":"2022","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2022.107228_bb0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/oxfordjournals.eurheartj.a060042","article-title":"Cardiodepressant effects of mexiletine in patients with severe left ventricular dysfunction","volume":"13","author":"Gottlieb","year":"1992","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1016\/j.vascn.2022.107228_bb0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/btpr.2612","article-title":"Rapid fabrication of detachable three-dimensional tissues by layering of cell sheets with heating centrifuge","volume":"34","author":"Haraguchi","year":"2018","journal-title":"Biotechnology Progress"},{"issue":"2","key":"10.1016\/j.vascn.2022.107228_bb0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kft113","article-title":"Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays","volume":"134","author":"Harris","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2022.107228_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2019.10.001","article-title":"Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment","volume":"138","author":"Huang","year":"2020","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"5","key":"10.1016\/j.vascn.2022.107228_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1253\/circj.69.613","article-title":"Temporary overdriving pacing as an adjunct to antiarrhythmic drug therapy for electrical storm in acute myocardial infarction","volume":"69","author":"Kurisu","year":"2005","journal-title":"Circulation Journal"},{"issue":"4","key":"10.1016\/j.vascn.2022.107228_bb0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1476-5381.2011.01255.x","article-title":"How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?","volume":"163","author":"Laverty","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2022.107228_bb0055","first-page":"H98","article-title":"Transmembrane I Ca contributes to rate-dependent changes of action potentials in human ventricular myocytes","volume":"276","author":"Li","year":"1999","journal-title":"American Journal of Physiology"},{"issue":"1","key":"10.1016\/j.vascn.2022.107228_bb0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/toxsci\/kfx081","article-title":"Blinded contractility analysis in hiPSC-cardiomyocytes in engineered heart tissue format: comparison with human atrial trabeculae","volume":"158","author":"Mannhardt","year":"2017","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2022.107228_bb0065","doi-asserted-by":"crossref","first-page":"21747","DOI":"10.1038\/srep21747","article-title":"TRPV-1-mediated elimination of residual iPS cells in bioengineered cardiac cell sheet tissues","volume":"6","author":"Matsuura","year":"2016","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.vascn.2022.107228_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbrc.2012.07.089","article-title":"Creation of human cardiac cell sheets using pluripotent stem cells","volume":"425","author":"Matsuura","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.vascn.2022.107228_bb0075","first-page":"66","article-title":"Ranolazine preserves and improves left ventricular ejection fraction and autonomic measures when added to guideline-driven therapy in chronic heart failure","volume":"9","author":"Murray","year":"2014","journal-title":"Heart International"},{"key":"10.1016\/j.vascn.2022.107228_bb0080","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3389\/fphys.2017.01073","article-title":"Adult human primary cardiomyocyte-based model for the simultaneous prediction of drug-induced inotropic and pro-arrhythmia risk","volume":"8","author":"Nguyen","year":"2017","journal-title":"Frontiers in Physiology"},{"issue":"1","key":"10.1016\/j.vascn.2022.107228_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.RES.85.1.38","article-title":"Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium","volume":"85","author":"Pieske","year":"1999","journal-title":"Circulation Reseach"},{"key":"10.1016\/j.vascn.2022.107228_bb0090","article-title":"Inotropic assessment in engineered 3D cardiac tissues using human induced pluripotent stem cell-derived cardiomyocytes in the biowireTM II platform","volume":"105","author":"Qu","year":"2020","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2022.107228_bb0095","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/00005344-199220002-00015","article-title":"Dofetilide, a novel class III antiarrhthmic agent","volume":"20","author":"Rasmussen","year":"1992","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"7700","key":"10.1016\/j.vascn.2022.107228_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vascn.2022.107228_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/toxsci\/kfaa058","article-title":"Blinded, multicenter evaluation of drug-induced changes in contractility using human-induced pluripotent stem cell-derived cardiomyocytes","volume":"176","author":"Saleem","year":"2020","journal-title":"Toxicological Sciences"},{"issue":"5","key":"10.1016\/j.vascn.2022.107228_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198026","article-title":"Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue","volume":"13","author":"Sasaki","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2022.107228_bb0115","doi-asserted-by":"crossref","first-page":"45499","DOI":"10.1038\/srep45499","article-title":"Tubular cardiac tissues derived from human induced pluripotent stem cells generate pulse pressure in vivo","volume":"7","author":"Seta","year":"2017","journal-title":"Scientific Reports"},{"issue":"17","key":"10.1016\/j.vascn.2022.107228_bb0120","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0002-9149(90)91104-E","article-title":"Long-term effect of mexiletine on left ventricular function and relation to suppression of ventricular arrhythmia","volume":"66","author":"Singh","year":"1990","journal-title":"The American Journal of Cardiology"},{"issue":"2","key":"10.1016\/j.vascn.2022.107228_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vascn.2006.05.006","article-title":"Isolated heart perfusion according to Langendorff-still viable in the new millennium","volume":"55","author":"Skrzypiec-Spring","year":"2007","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"6","key":"10.1016\/j.vascn.2022.107228_bb0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0002-9149(84)90251-0","article-title":"Effects of oral mexiletine on left and right ventricular function","volume":"54","author":"Stein","year":"1984","journal-title":"The American Journal of Cardiology."},{"issue":"5","key":"10.1016\/j.vascn.2022.107228_bb0135","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vascn.2022.107228_bb0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/toxsci\/kfaa010","article-title":"Effects of electrical stimulation on hiPSC-CM responses to classic ion channel blockers","volume":"174","author":"Wei","year":"2020","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2022.107228_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vascn.2017.12.004","article-title":"Response of human induced pluripotent stem cell-derived cardiomyocytes to several pharmacological agents when intrinsic syncytial pacing is overcome by acute external stimulation","volume":"91","author":"Zeng","year":"2018","journal-title":"Journal of Pharmacological and Toxicological Methods"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:06:08Z","timestamp":1761005168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871922000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":29,"alternative-id":["S1056871922000752"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107228","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of beating rate control for the analysis of drug effects on contractility in human induced pluripotent stem cell-derived cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107228"}}